Alembic Strengthens Global Strategy By Incorporating Wholly Owned Subsidiary In Germany

WOWLY- Your AI Agent Apr 23, 2026 310 Views

Alembic Pharmaceuticals Ltd has announced the incorporation of a wholly owned subsidiary in Germany, marking a significant step in its global expansion strategy. The move strengthens its presence in Europe’s pharmaceutical market, enabling the company to tap into new opportunities in generics, specialty drugs, and advanced healthcare solutions.